FR2381520A1 - Compositions pour usage rectal - Google Patents
Compositions pour usage rectalInfo
- Publication number
- FR2381520A1 FR2381520A1 FR7805692A FR7805692A FR2381520A1 FR 2381520 A1 FR2381520 A1 FR 2381520A1 FR 7805692 A FR7805692 A FR 7805692A FR 7805692 A FR7805692 A FR 7805692A FR 2381520 A1 FR2381520 A1 FR 2381520A1
- Authority
- FR
- France
- Prior art keywords
- compositions
- rectal use
- rectal
- water
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Abstract
La présente invention concerne des compositions pour usage rectal. La composition formant une solution micellaire pour usage rectal comprend une drogue soluble à l'eau faiblement absorbable lors d'une administration par voie orale, au moins un des composés constitués par un acide gras intermédiaire et le mono ou di-glycéride dudit acide, et au moins un des composés constitues par l'acide biliaire et/ou un agent tensio-actif non ionique, et de l'eau. La présente invention permet une administration rectale de compositions habituellement administrées par injection.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2172077A JPS53107408A (en) | 1977-02-28 | 1977-02-28 | Micellar preparation for rectal infusion |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2381520A1 true FR2381520A1 (fr) | 1978-09-22 |
FR2381520B1 FR2381520B1 (fr) | 1981-05-08 |
Family
ID=12062904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7805692A Granted FR2381520A1 (fr) | 1977-02-28 | 1978-02-28 | Compositions pour usage rectal |
Country Status (5)
Country | Link |
---|---|
US (1) | US4156719A (fr) |
JP (1) | JPS53107408A (fr) |
DE (1) | DE2807248C2 (fr) |
FR (1) | FR2381520A1 (fr) |
GB (1) | GB1601613A (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2455897A1 (fr) * | 1979-05-10 | 1980-12-05 | Kyoto Pharma Ind | Adjuvant du type acide gras pour favoriser l'absorption de substances pharmacologiquement actives par le rectum, composition de base pour administration rectale comprenant cet adjuvant et composition pharmaceutique comprenant cet adjuvant |
EP0147526A1 (fr) * | 1983-08-27 | 1985-07-10 | BASF Aktiengesellschaft | Méthode pour l'augmentation de la résorption entérique de l'héparine et préparations contenant de l'héparine ainsi obtenues |
EP0211434A2 (fr) * | 1985-08-05 | 1987-02-25 | F. Hoffmann-La Roche Ag | Formes de dosage rectales pour le ceftriaxone |
FR2620336A1 (fr) * | 1987-09-15 | 1989-03-17 | Sandoz Sa | Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments |
DE3830494A1 (de) * | 1987-09-15 | 1989-03-23 | Sandoz Ag | Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe |
WO1991001129A1 (fr) * | 1989-07-25 | 1991-02-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Preparation pharmaceutique pour administration rectale |
US5378470A (en) * | 1989-07-25 | 1995-01-03 | Henning Berlin Gmbh | Rectally administered pharmaceutical preparation |
WO1995013795A1 (fr) * | 1993-11-16 | 1995-05-26 | Cortecs Limited | Preparations hydrophobes |
WO1996017594A1 (fr) * | 1994-12-09 | 1996-06-13 | Cortecs Limited | Agents sequestrants |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5554666U (fr) * | 1978-10-02 | 1980-04-12 | ||
DE3171774D1 (en) | 1980-03-31 | 1985-09-19 | Teijin Ltd | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
EP0071433A1 (fr) * | 1981-07-28 | 1983-02-09 | Kowa Company, Ltd. | Médicament pour le traitement du diabète |
SE8206744D0 (sv) * | 1982-11-26 | 1982-11-26 | Fluidcarbon International Ab | Preparat for kontrollerad avgivning av substanser |
US5116817A (en) * | 1982-12-10 | 1992-05-26 | Syntex (U.S.A.) Inc. | LHRH preparations for intranasal administration |
CA1256799A (fr) * | 1984-02-22 | 1989-07-04 | Walter Fuller | Suppositoires |
GB8417895D0 (en) * | 1984-07-13 | 1984-08-15 | Marples B A | Pharmaceutical anti-fungal composition |
JPS60149519A (ja) * | 1984-09-03 | 1985-08-07 | Kyoto Yakuhin Kogyo Kk | 直腸投与用組成物 |
US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
JPS61204227U (fr) * | 1985-06-10 | 1986-12-23 | ||
CA1331559C (fr) * | 1986-04-21 | 1994-08-23 | Jon Joseph Kabara | Compositions et methodes pour la conservation antimicrobienne |
US5208257A (en) * | 1986-04-21 | 1993-05-04 | Kabara Jon J | Topical antimicrobial pharmaceutical compositions and methods |
US5389366A (en) * | 1986-09-19 | 1995-02-14 | Yamanouchi Pharmaceutical Co., Ltd. | Neocarzinostatin derivative composition for oral administration |
GB8630273D0 (en) * | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
US5030442A (en) * | 1987-03-30 | 1991-07-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition |
HU203204B (en) * | 1987-09-15 | 1991-06-28 | Sandoz Ag | Process for producing suppository containing calcitonin and taurocholic acid |
US5756450A (en) * | 1987-09-15 | 1998-05-26 | Novartis Corporation | Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
US5001112A (en) * | 1988-04-12 | 1991-03-19 | Bristol-Myers Company | Antitumor antibiotic kedarcidin |
US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
GB2222770B (en) * | 1988-09-16 | 1992-07-29 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporins |
CA2033725C (fr) * | 1990-01-24 | 2001-05-29 | Folker Pittrof | Compositions pharmaceutiques et cosmetiques |
JP3249147B2 (ja) * | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
US5571517A (en) * | 1990-08-13 | 1996-11-05 | Yesair; David W. | Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
DE69109297T2 (de) * | 1990-08-13 | 1995-11-09 | David W Yesair | Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien. |
US5891466A (en) * | 1990-08-13 | 1999-04-06 | Yesair; David W. | Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories |
US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
HU208084B (en) * | 1991-10-31 | 1993-08-30 | Hyd Kutato Fejlesztoe Kft | Process for producing compositions suitable for curing tumorous diseases |
US5342612A (en) * | 1991-12-20 | 1994-08-30 | American Cyanamid Company | Compositions for the treatment of mammalian diseases |
ES2098739T3 (es) | 1992-05-13 | 1997-05-01 | Sandoz Ltd | Composiciones oftalmicas conteniendo una cyclosporin. |
US5281420A (en) * | 1992-05-19 | 1994-01-25 | The Procter & Gamble Company | Solid dispersion compositions of tebufelone |
GB9212511D0 (en) * | 1992-06-12 | 1992-07-22 | Cortecs Ltd | Pharmaceutical compositions |
EP0589843B1 (fr) | 1992-09-25 | 2001-11-28 | Novartis AG | Compositions pharmaceutiques comprenant de la cyclosporine |
SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
US20020099067A1 (en) * | 1993-07-08 | 2002-07-25 | Ulrich Posanski | Pharmaceutical compositions for sparingly soluble therapeutic agents |
US6087391A (en) * | 1994-03-14 | 2000-07-11 | Weidner; Morten Sloth | Method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
RU2158601C2 (ru) | 1994-11-03 | 2000-11-10 | Новартис Аг | Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения |
AU6869996A (en) * | 1995-09-13 | 1997-04-01 | Morten Sloth Weidner | Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them |
DE19544507B4 (de) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
GB9613858D0 (en) * | 1996-07-02 | 1996-09-04 | Cortecs Ltd | Hydrophobic preparations |
NZ336900A (en) * | 1997-01-30 | 2001-06-29 | Novartis Ag | Hard gelatine capsules containing pharmaceutical compositions comprising cyclosporin A and being substantially free of any oil |
DE19722831A1 (de) * | 1997-05-30 | 1998-12-03 | Univ Halle Wittenberg | Vehikelsysteme für Arzneistoffe |
US7070799B1 (en) * | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
US6350458B1 (en) | 1998-02-10 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Mixed micellar drug deliver system and method of preparation |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
US6451286B1 (en) | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6982281B1 (en) * | 2000-11-17 | 2006-01-03 | Lipocine Inc | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
US6458383B2 (en) | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
US7732404B2 (en) * | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
US6867183B2 (en) * | 2001-02-15 | 2005-03-15 | Nobex Corporation | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |
US6770625B2 (en) * | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
US7196059B2 (en) * | 2001-09-07 | 2007-03-27 | Biocon Limited | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith |
US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
GB2398495B (en) * | 2003-01-23 | 2007-08-22 | Kent G Lau | A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug |
CA2536283A1 (fr) * | 2003-08-20 | 2005-03-03 | Ajinomoto Co., Inc. | Preparations pharmaceutiques possedant une solubilite accrue |
JP2006199589A (ja) * | 2003-09-03 | 2006-08-03 | Ltt Bio-Pharma Co Ltd | 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤 |
US20060003002A1 (en) * | 2003-11-03 | 2006-01-05 | Lipocine, Inc. | Pharmaceutical compositions with synchronized solubilizer release |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
AU2005329255B2 (en) | 2004-04-15 | 2010-09-30 | Chiasma, Inc. | Compositions capable of facilitating penetration across a biological barrier |
GB0522942D0 (en) * | 2005-11-10 | 2005-12-21 | Leigh Steven | Dissolution composition |
GB0623768D0 (en) * | 2006-11-28 | 2007-01-10 | Chopra Sunil | A bleomycin preparation for use against skin tumours |
JP5623406B2 (ja) | 2008-09-17 | 2014-11-12 | キアズマ インコーポレイテッド | 医薬組成物および関連する送達方法 |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
EP2338476B1 (fr) * | 2009-12-02 | 2012-06-20 | Bettina Heil | Suppositoire pour administration rectale, vaginale ou urétrale contenant un probiotique, un antibiotique et un acide gras insaturé non-estérifié |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
AU2016215350B2 (en) | 2015-02-03 | 2021-11-25 | Amryt Endo, Inc. | Method of treating diseases |
US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
WO2019182501A1 (fr) | 2018-03-19 | 2019-09-26 | Epicyt Pharma Ab | Composition destinée à être utilisée dans le traitement d'états provoqués par une déficience en calcium |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL45481C (fr) * | 1900-01-01 | |||
DE576616C (de) * | 1929-07-28 | 1933-05-12 | Wanderer Werke Vorm Winklhofer | Verbindung einer Rechenmaschine mit einer Kartenlochmaschine |
CH211204A (de) * | 1938-12-13 | 1940-08-31 | Chem Ind Basel | Verfahren zur Herstellung einer Suppositoriengrundmasse. |
DE932083C (de) * | 1954-03-31 | 1955-08-22 | Upha Chem Pharm Praeparate G M | Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon |
FR1100599A (fr) * | 1953-05-19 | 1955-09-21 | Edelfettwerke Gmbh | Procédé de préparation d'excipients pour la fabrication de pommades et suppositoires |
DE1916084A1 (de) * | 1968-03-28 | 1969-10-16 | Kyowa Hakko Kogyo Kk | Suppositorien mit Wasser als Vehiculm |
FR2096879A1 (en) * | 1970-07-09 | 1972-03-03 | Rougier Andre | Antibiotic/corticosteroid solns - for rectal administration |
FR2183677A1 (fr) * | 1972-03-06 | 1973-12-21 | Takeda Chemical Industries Ltd | |
FR2277594A1 (fr) * | 1974-07-10 | 1976-02-06 | Pfrimmer & Co J | Solution d'infusion pour nutrition par voie parenterale |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1904257A (en) * | 1926-10-29 | 1933-04-18 | Firm Of Chemical Works Formerl | Supersaturated calcium gluconate solution |
US2472640A (en) * | 1945-02-10 | 1949-06-07 | Sharp & Dohme Inc | Clear aqueous solutions of tyrothricin |
US2865859A (en) * | 1956-11-09 | 1958-12-23 | Irwin I Lubowe | Solubilizing of mineral, vegetable, animal oils for cosmetic, pharmaceutical and industrial purposes |
US3089818A (en) * | 1960-06-02 | 1963-05-14 | Baxter Laboratories Inc | Water dispersible antibiotics |
US3220923A (en) * | 1961-10-31 | 1965-11-30 | Bayer Ag | Aqueous injectable compositions and methods for effecting narcosis |
US3219529A (en) * | 1962-10-04 | 1965-11-23 | American Cyanamid Co | Stable tetracycline solutions |
GB1171125A (en) * | 1966-06-08 | 1969-11-19 | Glaxo Lab Ltd | Improvements in or relating to Injectable Preparations |
JPS4872316A (fr) * | 1971-12-29 | 1973-09-29 | ||
JPS4930519A (fr) * | 1972-07-14 | 1974-03-19 | ||
JPS4950119A (fr) * | 1972-09-21 | 1974-05-15 | ||
JPS563846B2 (fr) * | 1972-10-12 | 1981-01-27 | ||
USRE28819E (en) | 1972-12-08 | 1976-05-18 | Syntex (U.S.A.) Inc. | Dialkylated glycol compositions and medicament preparations containing same |
JPS5538925B2 (fr) * | 1973-11-08 | 1980-10-07 | ||
BE816414A (fr) * | 1974-06-17 | 1974-10-16 | Fil fourre pour le soudage a l'arc electrique d'aciers doux ou faiblement allies. |
-
1977
- 1977-02-28 JP JP2172077A patent/JPS53107408A/ja active Granted
-
1978
- 1978-02-21 DE DE2807248A patent/DE2807248C2/de not_active Expired
- 1978-02-23 US US05/880,603 patent/US4156719A/en not_active Expired - Lifetime
- 1978-02-28 FR FR7805692A patent/FR2381520A1/fr active Granted
- 1978-02-28 GB GB7926/78A patent/GB1601613A/en not_active Expired
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL45481C (fr) * | 1900-01-01 | |||
DE576616C (de) * | 1929-07-28 | 1933-05-12 | Wanderer Werke Vorm Winklhofer | Verbindung einer Rechenmaschine mit einer Kartenlochmaschine |
CH211204A (de) * | 1938-12-13 | 1940-08-31 | Chem Ind Basel | Verfahren zur Herstellung einer Suppositoriengrundmasse. |
FR1100599A (fr) * | 1953-05-19 | 1955-09-21 | Edelfettwerke Gmbh | Procédé de préparation d'excipients pour la fabrication de pommades et suppositoires |
DE932083C (de) * | 1954-03-31 | 1955-08-22 | Upha Chem Pharm Praeparate G M | Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon |
DE1916084A1 (de) * | 1968-03-28 | 1969-10-16 | Kyowa Hakko Kogyo Kk | Suppositorien mit Wasser als Vehiculm |
FR2096879A1 (en) * | 1970-07-09 | 1972-03-03 | Rougier Andre | Antibiotic/corticosteroid solns - for rectal administration |
FR2183677A1 (fr) * | 1972-03-06 | 1973-12-21 | Takeda Chemical Industries Ltd | |
FR2277594A1 (fr) * | 1974-07-10 | 1976-02-06 | Pfrimmer & Co J | Solution d'infusion pour nutrition par voie parenterale |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2455897A1 (fr) * | 1979-05-10 | 1980-12-05 | Kyoto Pharma Ind | Adjuvant du type acide gras pour favoriser l'absorption de substances pharmacologiquement actives par le rectum, composition de base pour administration rectale comprenant cet adjuvant et composition pharmaceutique comprenant cet adjuvant |
EP0147526A1 (fr) * | 1983-08-27 | 1985-07-10 | BASF Aktiengesellschaft | Méthode pour l'augmentation de la résorption entérique de l'héparine et préparations contenant de l'héparine ainsi obtenues |
EP0211434A2 (fr) * | 1985-08-05 | 1987-02-25 | F. Hoffmann-La Roche Ag | Formes de dosage rectales pour le ceftriaxone |
EP0211434A3 (fr) * | 1985-08-05 | 1987-10-07 | F. Hoffmann-La Roche Ag | Formes de dosage rectales pour le ceftriaxone |
GR880100602A (el) * | 1987-09-15 | 1989-06-22 | Sandoz Ag | Υδατοδιαλυτοι μονοεστερες ως διαλυτοποιητες για φαρμακολογικως δραστικες ενωσεις και φαρμακευτικα εκδοχα |
DE3830494A1 (de) * | 1987-09-15 | 1989-03-23 | Sandoz Ag | Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe |
FR2620336A1 (fr) * | 1987-09-15 | 1989-03-17 | Sandoz Sa | Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments |
BE1001204A5 (fr) * | 1987-09-15 | 1989-08-16 | Sandoz Sa | Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments. |
DE3830494B4 (de) * | 1987-09-15 | 2006-05-18 | Novartis Ag | Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe |
WO1991001129A1 (fr) * | 1989-07-25 | 1991-02-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Preparation pharmaceutique pour administration rectale |
US5378470A (en) * | 1989-07-25 | 1995-01-03 | Henning Berlin Gmbh | Rectally administered pharmaceutical preparation |
WO1995013795A1 (fr) * | 1993-11-16 | 1995-05-26 | Cortecs Limited | Preparations hydrophobes |
US6368619B1 (en) | 1993-11-16 | 2002-04-09 | Provalis Uk Limited | Hydrophobic preparations of hydrophilic species and process for their preparation |
WO1996017594A1 (fr) * | 1994-12-09 | 1996-06-13 | Cortecs Limited | Agents sequestrants |
Also Published As
Publication number | Publication date |
---|---|
DE2807248A1 (de) | 1978-08-31 |
FR2381520B1 (fr) | 1981-05-08 |
US4156719A (en) | 1979-05-29 |
JPS5619847B2 (fr) | 1981-05-09 |
GB1601613A (en) | 1981-11-04 |
JPS53107408A (en) | 1978-09-19 |
DE2807248C2 (de) | 1986-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2381520A1 (fr) | Compositions pour usage rectal | |
AP1422A (en) | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. | |
UY27320A1 (es) | Nuevas composiciones farmacéuticas | |
JPS5412381A (en) | N-alkylpiperidine derivative | |
ES482357A1 (es) | Procedimiento para preparar compuestos prostanoides. | |
EP1304125A3 (fr) | Agent diagnostique pour la fonction hépatique | |
ES479410A1 (es) | Un procedimiento para la preparacion de derivados del acido 4-tiazolidincarboxilico. | |
KR840000236A (ko) | 포유류의 국부용 제형의 수분 손실량을 극소화시키는 방법 | |
NL7705591A (nl) | Werkwijze ter bereiding van reukstofcomposities onder toepassing van alifatische 2-methyl-2-al- kyl-alkaanzuuresters alsmede aldus bereide reuk- stofcomposities. | |
FR2355091A1 (fr) | Compositions de phosphonomethylaminocarboxylates et leur utilisation pour l'inhibition de la corrosion de metaux dans des systemes aqueux | |
HUP0203236A2 (hu) | Orális és helyi beadásra szolgáló gyógyszerkészítmények | |
DE19975059I2 (de) | (2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio-essigsäure, ihre Salze und Ester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel. | |
FR2354761A1 (fr) | Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques | |
HUP0003517A2 (hu) | Kelátképzők lipofil diészterei, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
ES511962A0 (es) | "procedimiento para la preparacion de composiciones de ferormonas aldehidicas de lenta liberacion del compuesto activo". | |
FR2433506A1 (fr) | Derives de 2-acyl-6-aminomethylphenol et procede permettant leur preparation | |
FR2429201A1 (fr) | Sulfoxydes utilisables comme agents initiateurs de photopolymerisation | |
JPS549240A (en) | New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component | |
FR2376863A1 (fr) | Determination du 1a,25-dihydroxycholecalciferol | |
JPS523046A (en) | Prepration of 4-homotwistane-3-carboxylic acid esters | |
FR2431861A1 (fr) | Composition destinee a l'hygiene buccale | |
FR2393578A1 (fr) | Composition antibacterienne a base d'acide 6-(d(-)-a-(4-ethyl-2,3-dioxo-1-piperazinylcarbonylamino)phenylacetamido) penicillanique | |
ES2054827T3 (es) | Uso de alquil fosfatos para la estabilizacion de composiciones tixotropicas. | |
JPS5395912A (en) | New derivative of active acetic acid ulceratives | |
JPS57158719A (en) | Rectal administration pharmaceutical |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |